These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29356462)

  • 1. A randomized multicenter clinical trial of
    Mu R; Liang J; Sun L; Zhang Z; Liu X; Huang C; Zhu P; Zuo X; Gu J; Li X; Li X; Liu Y; Feng P; Li Z
    Int J Rheum Dis; 2018 Jan; 21(1):161-169. PubMed ID: 29356462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (99) Tc-methylene diphosphonate improves rheumatoid arthritis disease activity by increasing the frequency of peripheral γδ T cells and CD4(+) CD25(+) Foxp3(+) Tregs.
    Su D; Shen M; Gu B; Wang X; Wang D; Li X; Sun L
    Int J Rheum Dis; 2016 Jun; 19(6):586-93. PubMed ID: 24467668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Yunke (technetium-99 conjugated with methylene diphosphonate; (99)Tc-MDP) and/or colloidal chromic phosphate phosphonium-32, alone and in combination, in rats with adjuvant arthritis.
    Wang L; Gu Q; Xu Y; Li S; Gui J; Yang J; Yao Q; Ji Y
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):23-8. PubMed ID: 18047623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Tc-99m MDP, Tc-99m HSA and Tc-99m HIG uptake in rheumatoid arthritis and its variants.
    Sahin M; Bernay I; Basoglu T; Canturk F
    Ann Nucl Med; 1999 Dec; 13(6):389-95. PubMed ID: 10656272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of technetium-99 conjugated with methylene diphosphonate on IgM-RF, IgG-RF and IgA-RF.
    Huang A; Yu L; Shen L
    J Huazhong Univ Sci Technolog Med Sci; 2003; 23(3):266-8. PubMed ID: 14526429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and safety of 99Tc-methylene diphosphonate as a disease-modifying anti-rheumatic drug (DMARD) in combination with conventional synthetic (cs) DMARDs in the treatment of rheumatoid arthritis: A systematic review and meta-analysis of 34 randomized controlled trials.
    Deng G; Chen X; Shao L; Wu Q; Wang S
    Heliyon; 2023 Nov; 9(11):e21691. PubMed ID: 37942155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Tc-99m HIG and three-phase Tc-99m MDP bone scintigraphy for evaluating the efficacy of Yttrium-90 silicate radionuclide synovectomy.
    Arzu Gencoglu E; Aras G; Kucuk O; Atay G; Tutak I; Ataman S; Soylu A; Ibis E
    Clin Nucl Med; 2003 Apr; 28(4):277-85. PubMed ID: 12642704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results.
    Ruperto N; Nikishina I; Pachanov ED; Shachbazian Y; Prieur AM; Mouy R; Joos R; Zulian F; Schwarz R; Artamonova V; Emminger W; Bandeira M; Buoncompagni A; Foeldvari I; Falcini F; Baildam E; Kone-Paut I; Alessio M; Gerloni V; Lenhardt A; Martini A; Hanft G; Sigmund R; Simianer S;
    Arthritis Rheum; 2005 Feb; 52(2):563-72. PubMed ID: 15692986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compartment syndrome caused by computed tomography contrast infiltration seen on a Tc-99m methylene diphosphonate bone scan.
    Gerard PS; Gerczuk PZ; Idupuganti R; Patnana M; Geller MD
    Clin Nucl Med; 2008 Jan; 33(1):36-7. PubMed ID: 18097256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99 conjugated with methylene diphosphonate ameliorates ovariectomy-induced osteoporotic phenotype without causing osteonecrosis in the jaw.
    Zhao Y; Wang L; Liu Y; Akiyama K; Chen C; Atsuta I; Zhou T; Duan X; Jin Y; Shi S
    Calcif Tissue Int; 2012 Dec; 91(6):400-8. PubMed ID: 23064899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative measurements of bone remodeling using 99mTc-methylene diphosphonate bone scans and blood sampling.
    Moore AE; Blake GM; Fogelman I
    J Nucl Med; 2008 Mar; 49(3):375-82. PubMed ID: 18287266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidants Taken Orally prior to Diagnostic Radiation Exposure Can Prevent DNA Injury.
    Velauthapillai N; Barfett J; Jaffer H; Mikulis D; Murphy K
    J Vasc Interv Radiol; 2017 Mar; 28(3):406-411. PubMed ID: 28034704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of ultrafiltration as a method of measuring free 99mTc-MDP.
    Moore AE; Hain SF; Blake GM; Fogelman I
    J Nucl Med; 2003 Jun; 44(6):891-7. PubMed ID: 12791815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.
    Gong W; Dou H; Liu X; Sun L; Hou Y
    Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):886-93. PubMed ID: 23013134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of intramuscular and oral meloxicam in rheumatoid arthritis patients.
    Combe B; Vélicitat P; Garzón N; Bluhmki E
    Inflamm Res; 2001 Mar; 50 Suppl 1():S10-6. PubMed ID: 11339515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99 Conjugated with Methylene Diphosphonate Ameliorates Glucocorticoid Induced Osteoporosis by Inhibiting Osteoclastogenesis.
    Shi L; Ning Y; Xu L; Li J; Zhang X
    Biomed Res Int; 2018; 2018():7902760. PubMed ID: 30406140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative studies of bone in postmenopausal women using (18)F-fluoride and (99m)Tc-methylene diphosphonate.
    Blake GM; Park-Holohan SJ; Fogelman I
    J Nucl Med; 2002 Mar; 43(3):338-45. PubMed ID: 11884493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of 99Tc-MDP on cytokine production by peripheral blood mononuclear cells of patients with rheumatoid arthritis].
    Wu YG; Ma QL; Liu GF
    Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):173-5. PubMed ID: 12575354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of meloxicam in patients with rheumatoid arthritis.
    Lemmel EM; Bolten W; Burgos-Vargas R; Platt P; Nissilä M; Sahlberg D; Björneboe O; Baumgartner H; Valat JP; Franchimont P; Bluhmki E; Hanft G; Distel M
    J Rheumatol; 1997 Feb; 24(2):282-90. PubMed ID: 9034984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose response and safety study of meloxicam up to 22.5 mg daily in rheumatoid arthritis: a 12 week multicenter, double blind, dose response study versus placebo and diclofenac.
    Furst DE; Kolba KS; Fleischmann R; Silverfield J; Greenwald M; Roth S; Hall DB; Roszko PJ;
    J Rheumatol; 2002 Mar; 29(3):436-46. PubMed ID: 11908554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.